These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8216455)

  • 21. Pharmacokinetics of cefodizime administered intravenously as a single-dose (1.0 and 2.0 g) to healthy adult volunteers.
    Bryskier A; Procyk T; Tremblay D; Lenfant B; Fourtillan JB
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():65-70. PubMed ID: 2074253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose.
    Chadha D; Wise R; Baldwin DR; Andrews JM; Ashby JP; Honeybourne D
    J Antimicrob Chemother; 1990 Jun; 25(6):959-63. PubMed ID: 2196260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penetration of ciprofloxacin in bronchial secretions after intravenous administration.
    Berré J; Thys JP; Husson M; Gangji D; Klastersky J
    J Antimicrob Chemother; 1988 Oct; 22(4):499-504. PubMed ID: 3204076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cefodizime in patients with various degrees of renal failure.
    Loffreda A; Lampa E; Lucarelli C; Amorena M; Contaldi C; Calderaro V; Rossi F
    Chemotherapy; 1999; 45(1):1-7. PubMed ID: 9876203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy.
    Bergogne-Bérézin E; Muller-Serieys C; Aubier M; Dombret MC
    Eur J Clin Pharmacol; 1994; 46(1):87-8. PubMed ID: 8005193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of cefodizime during continuous ambulatory peritoneal dialysis.
    Mendes P; Lameire N; Rosenkranz B; Malerczyk V; Damm D
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():89-93. PubMed ID: 2074257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of cefodizime in patients undergoing hemodialysis].
    Itagaki N; Hasegawa H; Sakaguchi M; Oono T; Iwamoto I; Horiuchi H; Tsujino M; Takahashi K; Imada A; Horiuchi A
    Jpn J Antibiot; 1991 Dec; 44(12):1392-6. PubMed ID: 1798074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E; Muller-Serieys C; Kafé H
    Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum and tissue levels of cefodizime in the pediatric patients].
    Matsuura K; Ogata T; Araki K; Kaneko A; Kawasaki H; Kobayashi M; Naoki I; Namikawa T; Andoh T; Yamamoto H
    Jpn J Antibiot; 1994 Aug; 47(8):1071-6. PubMed ID: 7933536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 g.
    Bryskier A; Procyk T; Tremblay D; Lenfant B; Fourtillan JB
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():59-63. PubMed ID: 2074252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary penetration of ceftazidime.
    Cazzola M; Gabriella Matera M; Polverino M; Santangelo G; De Franchis I; Rossi F
    J Chemother; 1995 Feb; 7(1):50-4. PubMed ID: 7629560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefodizime penetration into skin suction blister fluid following a single intravenous dose.
    Schäfer-Korting M; Korting HC; Maass L; Klesel N; Grigoleit HG; Mutschler E
    Eur J Clin Pharmacol; 1986; 30(3):295-8. PubMed ID: 3732363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The penetration of ofloxacin into bronchial secretions.
    Symonds J; Javaid A; Bone M; Turner A
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():91-5. PubMed ID: 3182469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bactericidal effect of cefodizime against beta-lactamase-producing Neisseria gonorrhoeae in vitro. A comparison of level profiles in serum and tissue after intramuscular and intravenous administration in man.
    Korting HC; Lukacs A; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1989 Jan; 39(1):31-3. PubMed ID: 2497751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients.
    Mazzei T; Novelli A; Esposito S; Fallani S; Noviello S; Cassetta MI; Conti S; Periti P
    J Chemother; 2000 Aug; 12(4):306-13. PubMed ID: 10949980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
    Andrews J; Honeybourne D; Ashby J; Jevons G; Fraise A; Fry P; Warrington S; Hawser S; Wise R
    J Antimicrob Chemother; 2007 Sep; 60(3):677-80. PubMed ID: 17623694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Placental passage of cefodizime].
    Berthelot G; Bornet M; Bergogne-Bérézin E; Ravina JH
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):699-701. PubMed ID: 3054750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic study of beta-lactam antibiotics in bronchial secretions.
    Bergogne-Berezin E; Morel C; Benard Y; Berthelot G; Kafe H
    Scand J Infect Dis Suppl; 1978; (14):267-72. PubMed ID: 279981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penetration of ampicillin into human bronchial secretions.
    Bergogne-Berezin E; Berthelot G; Kafe H; Morel C
    Infection; 1979; 7 Suppl 5():S463-4. PubMed ID: 511358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of cefodizime in patients with liver cirrhosis and ascites.
    el Touny M; el Guinaidy M; Abdel Bary M; Osman L; Sabbour MS
    Chemotherapy; 1992; 38(4):201-5. PubMed ID: 1473357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.